{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:18:35Z","timestamp":1740122315914,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10840-020-00877-w","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T12:02:20Z","timestamp":1600862540000},"page":"103-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The clinical impact of untreated slow ventricular tachycardia in patients carrying implantable cardiac defibrillators"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8689-4011","authenticated-orcid":false,"given":"David","family":"Calvo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Picazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Garc\u00eda-Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Rub\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Bautista","family":"Mart\u00ednez-Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An\u00edbal","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xabier","family":"Vi\u00f1olas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Alzueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Basterra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar","family":"Mor\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"877_CR1","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/heartjnl-2012-301853","volume":"98","author":"BD Atwater","year":"2012","unstructured":"Atwater BD, Daubert JP. Implantable cardioverter defibrillators: risks accompany the life-saving benefits. Heart. 2012;98:764\u201372.","journal-title":"Heart"},{"key":"877_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.cjca.2014.11.023","volume":"31","author":"R Proietti","year":"2015","unstructured":"Proietti R, Labos C, Davis M, Thanassoulis G, Santangeli P, Russo V, et al. A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality. Can J Cardiol. 2015;31:270\u20137.","journal-title":"Can J Cardiol"},{"key":"877_CR3","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","volume":"367","author":"AJ Moss","year":"2012","unstructured":"Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275\u201383.","journal-title":"N Engl J Med"},{"key":"877_CR4","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.2013.4598","volume":"309","author":"M Gasparini","year":"2013","unstructured":"Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JBM, et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA. 2013;309:1903\u201311.","journal-title":"JAMA"},{"key":"877_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0735-1097(00)00733-6","volume":"36","author":"D B\u00e4nsch","year":"2000","unstructured":"B\u00e4nsch D, Castrucci M, B\u00f6cker D, Breithardt G, Block M. Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: incidence, prediction and significance. J Am Coll Cardiol. 2000;36:557\u201365.","journal-title":"J Am Coll Cardiol"},{"key":"877_CR6","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/europace\/euz065","volume":"21","author":"MK Stiles","year":"2019","unstructured":"Stiles MK, Fauchier L, Morillo CA, Wilkoff BL, ESC Scientific Document Group. 2019 HRS\/EHRA\/APHRS\/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace. 2019;21:1442\u20133.","journal-title":"Europace"},{"key":"877_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/CIRCULATIONAHA.114.009468","volume":"130","author":"A Kloppe","year":"2014","unstructured":"Kloppe A, Proclemer A, Arenal A, Lunati M, Mart\u00ecnez Ferrer JB, Hersi A, et al. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial. Circulation. 2014;130:308\u201314.","journal-title":"Circulation"},{"key":"877_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00380-016-0850-x","volume":"32","author":"Y Hayashi","year":"2017","unstructured":"Hayashi Y, Takagi M, Kakihara J, Sakamoto S, Doi A, Sugioka K, et al. Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients. Heart Vessel. 2017;32:175\u201385.","journal-title":"Heart Vessel"},{"key":"877_CR9","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/jce.12699","volume":"26","author":"I Anguera","year":"2015","unstructured":"Anguera I, Dallaglio P, Mart\u00ednez-Ferrer J, Rodr\u00edguez A, Alzueta J, P\u00e9rez-Villacast\u00edn J, et al. Shock reduction with multiple bursts of antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: a multicenter study. J Cardiovasc Electrophysiol. 2015;26:774\u201382.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"877_CR10","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/01.CIR.0000140259.16185.7D","volume":"110","author":"D B\u00e4nsch","year":"2004","unstructured":"B\u00e4nsch D, Steffgen F, Gr\u00f6nefeld G, Wolpert C, B\u00f6cker D, Mletzko R-U, et al. The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias. Circulation. 2004;110:1022\u20139.","journal-title":"Circulation"},{"key":"877_CR11","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.110.976092","volume":"122","author":"GI Fishman","year":"2010","unstructured":"Fishman GI, Chugh SS, Dimarco JP, Albert CM, Anderson ME, Bonow RO, et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation. 2010;122:2335\u201348.","journal-title":"Circulation"},{"key":"877_CR12","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/europace\/euv393","volume":"18","author":"A Fontenla","year":"2016","unstructured":"Fontenla A, Mart\u00ednez-Ferrer JB, Alzueta J, Vi\u00f1olas X, Garc\u00eda-Alberola A, Brugada J, et al. Incidence of arrhythmias in a large cohort of patients with current implantable cardioverter-defibrillators in Spain: results from the UMBRELLA Registry. Europace. 2016;18:1726\u201334.","journal-title":"Europace"},{"key":"877_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An introduction to the bootstrap","author":"BTR Efron","year":"1993","unstructured":"Efron BTR. An introduction to the bootstrap. New-York: Chapman & Hall; 1993."},{"key":"877_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jspi.2011.09.003","volume":"142","author":"P Mart\u00ednez-Camblor","year":"2012","unstructured":"Mart\u00ednez-Camblor P, Corral N. A general bootstrap algorithm for hypothesis testing. J Statist Plann Inference. 2012;142:589\u2013600.","journal-title":"J Statist Plann Inference"},{"key":"877_CR15","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/CIRCULATIONAHA.105.533513","volume":"112","author":"N Sadoul","year":"2005","unstructured":"Sadoul N, Mletzko R, Anselme F, Bowes R, Sch\u00f6ls W, Kouakam C, et al. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation. 2005;112:946\u201353.","journal-title":"Circulation"},{"key":"877_CR16","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1161\/01.CIR.91.8.2204","volume":"91","author":"SO Nunain","year":"1995","unstructured":"Nunain SO, Roelke M, Trouton T, Osswald S, Kim YH, Sosa-Suarez G, et al. Limitations and late complications of third-generation automatic cardioverter-defibrillators. Circulation. 1995;91:2204\u201313.","journal-title":"Circulation"},{"key":"877_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/0735-1097(96)00123-4","volume":"28","author":"BH Sarter","year":"1996","unstructured":"Sarter BH, Finkle JK, Gerszten RE, Buxton AE. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? J Am Coll Cardiol. 1996;28:122\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"877_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/01.CIR.67.2.316","volume":"67","author":"PD Bourdillon","year":"1983","unstructured":"Bourdillon PD, Lorell BH, Mirsky I, Paulus WJ, Wynne J, Grossman W. Increased regional myocardial stiffness of the left ventricle during pacing-induced angina in man. Circulation. 1983;67:316\u201323.","journal-title":"Circulation"},{"key":"877_CR19","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa071098","volume":"359","author":"JE Poole","year":"2008","unstructured":"Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009\u201317.","journal-title":"N Engl J Med"},{"key":"877_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.hrthm.2009.11.027","volume":"7","author":"MO Sweeney","year":"2010","unstructured":"Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm. 2010;7:353\u201360.","journal-title":"Heart Rhythm"},{"key":"877_CR21","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/CIRCEP.114.001623","volume":"7","author":"A-C Ruwald","year":"2014","unstructured":"Ruwald A-C, Schuger C, Moss AJ, Kutyifa V, Olshansky B, Greenberg H, et al. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Circ Arrhythm Electrophysiol. 2014;7:785\u201392.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"877_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jacc.2006.03.037","volume":"48","author":"BL Wilkoff","year":"2006","unstructured":"Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM, et al. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol. 2006;48:330\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"877_CR23","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.hlc.2012.07.017","volume":"21","author":"MR Webber","year":"2012","unstructured":"Webber MR, Stiles MK. Recommendations for the programming of implantable cardioverter-defibrillators in New Zealand. Heart Lung Circ. 2012;21:765\u201377.","journal-title":"Heart Lung Circ"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-020-00877-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-020-00877-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-020-00877-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T05:21:49Z","timestamp":1633065709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-020-00877-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1007\/s10840-020-00877-w","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"type":"print","value":"1383-875X"},{"type":"electronic","value":"1572-8595"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"1 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"David Calvo MD has participated in the \u201cEpisode Review Committee\u201d of the study Umbrella, sponsored by Medtronic Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}